AsterDM Healthcare Q3FY22 PAT at Rs 148.34 cr.
Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021
Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021
The campaign aims to bring back focus on leprosy case detection, treatment and rehabilitation; especially in the context of neglect brought in by Covid-19 pandemic
Sun Pharma’s Q3FY22 operational performance was in line with I-direct estimates with sustained momentum and good growth across businesses
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
The target demographic will be those between the ages of 30 and 65 years
It has signed an MoU with Plan India to expand its reach to Karnataka
Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals
Pristyn Care operates on an innovative full- stack Care Delivery model to ensure that high quality surgical care is offered to patients at an affordable cost
It has a total of 50 ANDA approvals from USFDA
The tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency
Subscribe To Our Newsletter & Stay Updated